Michael Bretthauer - Nanotechnology

Author Information

Dr. Michael Bretthauer is associated with the Clinical Effectiveness Research Group at the University of Oslo and Oslo University Hospital in Oslo, Norway. His research primarily focuses on gastrointestinal diseases, with a specific interest in colorectal cancer screening and prevention.

Research Contributions

Dr. Michael Bretthauer has made significant contributions to the field of gastroenterology, particularly in the study of colorectal cancer, inflammatory bowel disease, and the application of artificial intelligence in diagnostic procedures. His recent works include studies on the increased risk of hepato-pancreato-biliary cancer in patients with inflammatory bowel disease, the cost-effectiveness of AI for screening colonoscopy, and the effectiveness of different polypectomy techniques. Additionally, his research encompasses the long-term impact of adenoma removal on colorectal cancer incidence and mortality, as well as the role of AI in real-time optical diagnosis during colonoscopy.

Aliases

Dr. Michael Bretthauer is also known as M. Bretthauer and M Bretthauer in various publications.

Publication and Citation Metrics

Metric Value
Citation Count 11,650
h-index 58
Paper Count 360

Publications:

DOI: 10.1002/ueg2.12230

Year: 2022

DOI: 10.1016/S0140-6736(20)32402-8

Year: 2021

Partnered Content Networks

Relevant Topics